Suppr超能文献

欧洲儿童肾脏替代治疗的人口统计学:ESPN/ERA-EDTA登记处报告

Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registry.

作者信息

Chesnaye Nicholas, Bonthuis Marjolein, Schaefer Franz, Groothoff Jaap W, Verrina Enrico, Heaf James G, Jankauskiene Augustina, Lukosiene Viktorija, Molchanova Elena A, Mota Conceicao, Peco-Antić Amira, Ratsch Ilse-Maria, Bjerre Anna, Roussinov Dimitar L, Sukalo Alexander, Topaloglu Rezan, Van Hoeck Koen, Zagozdzon Ilona, Jager Kitty J, Van Stralen Karlijn J

机构信息

Department of Medical Informatics, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

Pediatr Nephrol. 2014 Dec;29(12):2403-10. doi: 10.1007/s00467-014-2884-6. Epub 2014 Jul 21.

Abstract

BACKGROUND

The ESPN/ERA-EDTA Registry collects data on European children with end-stage renal disease receiving renal replacement therapy (RRT) who are listed on national and regional renal registries in Europe. In this paper we report on the analysis of demographic data collected from 2009 to 2011.

METHODS

Data on primary renal disease, incidence, prevalence, 4-year survival, transplantation rate and causes of death in paediatric patients receiving RRT were extracted from the ESPN/ERA-EDTA Registry for 37 European countries.

RESULTS

The incidence of RRT in paediatric patients in Europe during the study period was 5.5 cases per million age-related population (pmarp) in patients aged 0-14 years and varied markedly between countries (interquartile range 3.4-7.0 years). The prevalence of RRT was 27.9 pmarp and increased with age, with 67 % of prevalent patients living with a functioning graft. The probability of receiving a transplant within 4 years was 76.9 % and was lowest in patients aged 0-4 years (68.9 %). Mortality in paediatric patients treated with RRT was 55-fold higher than that of the general EU paediatric population. Overall survival at 4 years was 93.7 %, with the poorest survival in patients aged 0-4 years and in patients starting on dialysis. Infections (19.9 %) were the primary cause of death in European paediatric RRT patients.

CONCLUSION

Considerable variation exists in the current demographics of children treated with RRT across Europe.

摘要

背景

ESPN/ERA - EDTA注册机构收集了欧洲终末期肾病儿童接受肾脏替代治疗(RRT)的数据,这些儿童登记在欧洲各国和各地区的肾脏登记处。在本文中,我们报告了对2009年至2011年收集的人口统计学数据的分析。

方法

从ESPN/ERA - EDTA注册机构提取了37个欧洲国家接受RRT的儿科患者的原发性肾病、发病率、患病率、4年生存率、移植率和死亡原因的数据。

结果

在研究期间,欧洲0 - 14岁儿科患者的RRT发病率为每百万年龄相关人口5.5例(pmarp),各国之间差异显著(四分位间距为3.4 - 7.0例/百万年龄相关人口)。RRT患病率为27.9 pmarp,且随年龄增长而增加,67%的患病患者有功能正常的移植肾。4年内接受移植的概率为76.9%,在0 - 4岁患者中最低(68.9%)。接受RRT治疗的儿科患者的死亡率比欧盟普通儿科人群高55倍。4年总生存率为93.7%,0 - 4岁患者和开始透析的患者生存率最差。感染(19.9%)是欧洲儿科RRT患者的主要死亡原因。

结论

欧洲接受RRT治疗儿童的当前人口统计学情况存在相当大的差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验